Elanco was taking over Bayer AG, they started this process back in August 2019, and it was unclear if they would succeed. So I believe it all went through for them at the end of July this year. Perhaps their contribution to this has hindered their ability $$ wise, to partner with PAA. PAA may have been their back up plan . It doesn't take away the fact that the drug MPL works, and I am confident another big player will want in on this.
Its a good time to buy more IMO..
Ann: Elanco Option Update, page-80
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.81M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $275.8K | 1.451M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 348633 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 79367 | 2 |
View Market Depth
| Last trade - 13.59pm 03/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |